Market Currents
Drug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary...
-
Friday, November 9, 2012, 10:39 AM ETDrug developer Array BioPharma (ARRY -12.3%) slides after pricing an 18M share secondary offering at $3.65 per share, a 10% discount to yesterday's close. The company had 95.4M shares outstanding as of October, which would make the sale nearly a 19% dilution to its float.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
